IPAB sets aside Sutent patent rejection

07-06-2013

India’s Intellectual Property Appellate Board (IPAB) has set aside a decision revoking a Pfizer-licensed patent directed to cancer drug Sutent.


ipab, sugen, sutent, pfizer

WIPR